TEMPUS AI INC-CL A (1TEM.MI) Fundamental Analysis & Valuation

BIT:1TEM • US88023B1035

Current stock price

40.23 EUR
+3.14 (+8.47%)
Last:

This 1TEM.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1TEM.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1TEM has reported negative net income.
  • In the past year 1TEM has reported a negative cash flow from operations.
  • 1TEM had negative earnings in each of the past 5 years.
  • 1TEM had a negative operating cash flow in each of the past 5 years.
1TEM.MI Yearly Net Income VS EBIT VS OCF VS FCF1TEM.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -200M -400M -600M

1.2 Ratios

  • The Return On Assets of 1TEM (-10.77%) is worse than 90.48% of its industry peers.
  • Looking at the Return On Equity, with a value of -49.87%, 1TEM is doing worse than 85.71% of the companies in the same industry.
Industry RankSector Rank
ROA -10.77%
ROE -49.87%
ROIC N/A
ROA(3y)-46.17%
ROA(5y)-49.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1TEM.MI Yearly ROA, ROE, ROIC1TEM.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • 1TEM has a Gross Margin of 62.74%. This is amongst the best in the industry. 1TEM outperforms 85.71% of its industry peers.
  • 1TEM's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for 1TEM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.61%
GM growth 5Y32.65%
1TEM.MI Yearly Profit, Operating, Gross Margins1TEM.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. 1TEM.MI Health Analysis

2.1 Basic Checks

  • 1TEM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • 1TEM has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 1TEM has more shares outstanding
  • 1TEM has a worse debt/assets ratio than last year.
1TEM.MI Yearly Shares Outstanding1TEM.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
1TEM.MI Yearly Total Debt VS Total Assets1TEM.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 1.93 indicates that 1TEM is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of 1TEM (1.93) is worse than 61.90% of its industry peers.
  • A Debt/Equity ratio of 2.52 is on the high side and indicates that 1TEM has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.52, 1TEM is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF N/A
Altman-Z 1.93
ROIC/WACCN/A
WACC10.72%
1TEM.MI Yearly LT Debt VS Equity VS FCF1TEM.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • 1TEM has a Current Ratio of 3.13. This indicates that 1TEM is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.13, 1TEM belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
  • 1TEM has a Quick Ratio of 3.00. This indicates that 1TEM is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.00, 1TEM belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3
1TEM.MI Yearly Current Assets VS Current Liabilites1TEM.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. 1TEM.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 75.89% over the past year.
  • 1TEM shows a strong growth in Revenue. In the last year, the Revenue has grown by 83.41%.
  • The Revenue has been growing by 46.57% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)75.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)83.41%
Revenue growth 3Y58.29%
Revenue growth 5Y46.57%
Sales Q2Q%82.98%

3.2 Future

  • 1TEM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.75% yearly.
  • Based on estimates for the next years, 1TEM will show a very strong growth in Revenue. The Revenue will grow by 21.15% on average per year.
EPS Next Y23.65%
EPS Next 2Y38.37%
EPS Next 3Y44%
EPS Next 5Y47.75%
Revenue Next Year25.88%
Revenue Next 2Y23.76%
Revenue Next 3Y22.04%
Revenue Next 5Y21.15%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1TEM.MI Yearly Revenue VS Estimates1TEM.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
1TEM.MI Yearly EPS VS Estimates1TEM.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1TEM.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for 1TEM. In the last year negative earnings were reported.
  • Also next year 1TEM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1TEM.MI Price Earnings VS Forward Price Earnings1TEM.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1TEM.MI Per share data1TEM.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 1TEM's earnings are expected to grow with 44.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.37%
EPS Next 3Y44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1TEM.MI Dividend Analysis

5.1 Amount

  • 1TEM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1TEM.MI Fundamentals: All Metrics, Ratios and Statistics

TEMPUS AI INC-CL A

BIT:1TEM (4/1/2026, 7:00:00 PM)

40.23

+3.14 (+8.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-24
Earnings (Next)05-01
Inst Owners54.06%
Inst Owner ChangeN/A
Ins Owners8.12%
Ins Owner ChangeN/A
Market Cap7.19B
Revenue(TTM)1.27B
Net Income(TTM)-245.03M
Analysts77.39
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.19%
Min EPS beat(2)5.3%
Max EPS beat(2)35.09%
EPS beat(4)4
Avg EPS beat(4)16.89%
Min EPS beat(4)5.3%
Max EPS beat(4)35.09%
EPS beat(8)7
Avg EPS beat(8)3.83%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.51%
Min Revenue beat(2)0.36%
Max Revenue beat(2)0.66%
Revenue beat(4)4
Avg Revenue beat(4)2%
Min Revenue beat(4)0.36%
Max Revenue beat(4)4.94%
Revenue beat(8)5
Avg Revenue beat(8)0.85%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-27.77%
EPS NQ rev (3m)-26.54%
EPS NY rev (1m)-14.7%
EPS NY rev (3m)-17.63%
Revenue NQ rev (1m)0.9%
Revenue NQ rev (3m)1.34%
Revenue NY rev (1m)1.32%
Revenue NY rev (3m)1.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.54
P/FCF N/A
P/OCF N/A
P/B 16.92
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.4
Fwd EYN/A
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)-1.06
OCFYN/A
SpS6.16
BVpS2.38
TBVpS-1.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.77%
ROE -49.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.74%
FCFM N/A
ROA(3y)-46.17%
ROA(5y)-49.49%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.61%
GM growth 5Y32.65%
F-Score4
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 26.65%
Cap/Sales 2.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3
Altman-Z 1.93
F-Score4
WACC10.72%
ROIC/WACCN/A
Cap/Depr(3y)63.29%
Cap/Depr(5y)59.91%
Cap/Sales(3y)3.95%
Cap/Sales(5y)4.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y23.65%
EPS Next 2Y38.37%
EPS Next 3Y44%
EPS Next 5Y47.75%
Revenue 1Y (TTM)83.41%
Revenue growth 3Y58.29%
Revenue growth 5Y46.57%
Sales Q2Q%82.98%
Revenue Next Year25.88%
Revenue Next 2Y23.76%
Revenue Next 3Y22.04%
Revenue Next 5Y21.15%
EBIT growth 1Y63.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year223.45%
EBIT Next 3Y86.3%
EBIT Next 5Y73.91%
FCF growth 1Y-16.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.36%
OCF growth 3YN/A
OCF growth 5YN/A

TEMPUS AI INC-CL A / 1TEM.MI Fundamental Analysis FAQ

What is the fundamental rating for 1TEM stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1TEM.MI.


What is the valuation status of TEMPUS AI INC-CL A (1TEM.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to TEMPUS AI INC-CL A (1TEM.MI). This can be considered as Overvalued.


What is the profitability of 1TEM stock?

TEMPUS AI INC-CL A (1TEM.MI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for 1TEM stock?

The Earnings per Share (EPS) of TEMPUS AI INC-CL A (1TEM.MI) is expected to grow by 23.65% in the next year.